会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明授权
    • Percutaneous absorption preparation
    • 经皮吸收制剂
    • US6146656A
    • 2000-11-14
    • US232684
    • 1999-01-19
    • Mitsuhiko HoriKenjiro MinomiYoshihisa Nakano
    • Mitsuhiko HoriKenjiro MinomiYoshihisa Nakano
    • A61K9/70A61F13/02A61K31/445
    • A61K9/7053A61K9/7061
    • The present invention provides a percutaneous absorption preparation which comprises a skin contact base containing therein at least one active ingredient selected from the group consisting of biperiden, trihexyphenidyl and pharmacologically acceptable salts thereof in an amount of from 0.5 to 60% by weight. The percutaneous absorption preparation makes it possible to permit the percutaneous absorption of biperiden, trihexyphenidyl or pharmacologically acceptable salt thereof as an active ingredient so that the medicament can be used effectively and at the same time, pharmacological effects can be sustained long and administration can be carried out conveniently. In addition, the active ingredient contained in it can be maintained stably.
    • 本发明提供了一种经皮吸收制剂,其包含皮肤接触基质,其中含有至少一种活性成分,所述至少一种活性成分选自双倍哌啶,三己烯基及其药理学上可接受的盐,其量为0.5至60重量%。 经皮吸收制剂使得双倍哌啶,三己苯醌或其药理学上可接受的盐的经皮吸收作为活性成分成为可能,可以有效地使用药物,同时可以持续长时间的药理作用,可以进行给药 方便的 此外,其中包含的活性成分可以稳定地保持。
    • 8. 发明授权
    • Oral film-form base and oral film-form preparation
    • 口服薄膜形式基础和口服膜形式制备
    • US09289386B2
    • 2016-03-22
    • US13146829
    • 2009-03-06
    • Daisuke AsariMitsuhiko HoriKeiko Ogawa
    • Daisuke AsariMitsuhiko HoriKeiko Ogawa
    • A61K9/00A61K9/70A61K47/26A61K47/38
    • A61K9/0056A61K9/7007A61K47/26A61K47/38
    • The present invention provides a film-form base having one or more sugars or sugar alcohols dispersed as fine particles therein, and also provides a film-form preparation containing the base and a drug. The base is produced by dispersing, in an organic solvent having a solubility parameter of 9.7 or higher, an edible polymer soluble in water and the organic solvent, and particles of one or two or more compounds selected from the group consisting of mono- to hexasaccharide sugars and sugar alcohols thereof which have an average particle size of 0.1 μm to 60 μm and are insoluble in an organic solvent. The present invention can therefore provide oral film-form base and preparation which have a rapid dissolution profile in the mouth and sufficient film strength, and provide a reduced sticky sensation attributed to the water-soluble polymer in the mouth and an improved feel when handled with the fingers.
    • 本发明提供一种具有分散为细颗粒的一种或多种糖或糖醇的薄膜形式的底物,并且还提供含有该基质和药物的薄膜形式的制剂。 该碱是通过在溶解度参数为9.7以上的有机溶剂中分散可溶于水和有机溶剂的可食性聚合物,以及一种或两种以上选自单 - 六 糖和糖醇,其平均粒度为0.1〜60μm,不溶于有机溶剂。 因此,本发明可以提供在口腔中具有快速溶出曲线并具有足够的膜强度的口腔膜形式的基质和制剂,并且在口腔中提供归因于水溶性聚合物的降低的粘稠感和当用 手指。
    • 9. 发明授权
    • Percutaneous administration tape preparation
    • 经皮给药胶带制剂
    • US5814032A
    • 1998-09-29
    • US855897
    • 1997-05-12
    • Mitsuhiko HoriKatsuhiro YamamotoTetsuo Watanabe
    • Mitsuhiko HoriKatsuhiro YamamotoTetsuo Watanabe
    • A61K9/70A61K45/00A61K47/36A61K47/38A61K47/42A61F13/02B32B9/04
    • A61K9/7053A61K9/7061
    • There provided a percutaneous administration tape preparation which can attach well to the skin surface even in the case of the permeation of water after attaching and can be easily detached from the skin surface without giving the skin simulation such as peeling off and the injury of the horny layer. The percutaneous administration tape preparation comprises a sheet-form support, a drug-containing pressure-sensitive adhesive layer, and a separator, wherein the drug-containing pressure-sensitive adhesive layer comprises a uniform dispersed state containing from 50 to 95% by weight one or more kinds of elastomers, from 5 to 50% by weight a hygroscopic material, and a percutaneous absorption drug so that a part of the hygroscopic material contained therein remains on the applied surface at detaching the tape preparation from the applied surface.
    • 提供了经皮给药胶带制剂,即使在附着后水渗透的情况下也能很好地附着于皮肤表面,并且可以容易地从皮肤表面脱离,而不会产生皮肤模拟,例如剥离和角质的损伤 层。 经皮给药带制剂包括片状载体,含药物的压敏粘合剂层和隔膜,其中含药物的压敏粘合剂层包含均匀的分散状态,其含有50至95重量%的一种 或更多种类的弹性体,5至50重量%的吸湿材料和经皮吸收药物,使得其中包含的部分吸湿材料残留在施用的表面上,以将带制剂从施用的表面上分离。